Akorn, Inc. (NASDAQ:AKRX) has earned a consensus rating of “Hold” from the eighteen ratings firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $30.55.

A number of brokerages have recently issued reports on AKRX. Royal Bank Of Canada set a $34.00 price target on Akorn and gave the company a “hold” rating in a report on Tuesday, June 27th. Craig Hallum downgraded Akorn from a “buy” rating to a “hold” rating in a report on Tuesday, April 25th. Zacks Investment Research upgraded Akorn from a “sell” rating to a “hold” rating in a report on Monday, May 8th. Gabelli reiterated a “hold” rating on shares of Akorn in a report on Tuesday, April 25th. Finally, William Blair downgraded Akorn from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 25th.

Shares of Akorn (NASDAQ AKRX) traded up 0.16% on Monday, reaching $33.70. The company’s stock had a trading volume of 1,401,266 shares. The company has a market capitalization of $4.20 billion, a price-to-earnings ratio of 23.00 and a beta of 1.36. The company’s 50-day moving average is $33.32 and its 200 day moving average is $26.53. Akorn has a 12-month low of $17.61 and a 12-month high of $35.40.

A number of hedge funds have recently modified their holdings of the company. NEXT Financial Group Inc boosted its stake in shares of Akorn by 990.9% in the first quarter. NEXT Financial Group Inc now owns 3,000 shares of the company’s stock worth $100,000 after buying an additional 2,725 shares in the last quarter. Meadow Creek Investment Management LLC boosted its stake in shares of Akorn by 8.3% in the first quarter. Meadow Creek Investment Management LLC now owns 4,368 shares of the company’s stock worth $105,000 after buying an additional 336 shares in the last quarter. Glen Harbor Capital Management LLC boosted its stake in shares of Akorn by 8.3% in the first quarter. Glen Harbor Capital Management LLC now owns 5,304 shares of the company’s stock worth $128,000 after buying an additional 408 shares in the last quarter. Private Advisor Group LLC purchased a new stake in shares of Akorn during the first quarter worth approximately $164,000. Finally, LS Investment Advisors LLC boosted its stake in shares of Akorn by 21.8% in the first quarter. LS Investment Advisors LLC now owns 7,850 shares of the company’s stock worth $189,000 after buying an additional 1,407 shares in the last quarter. 76.09% of the stock is owned by institutional investors.

WARNING: “Akorn, Inc. (NASDAQ:AKRX) Given Average Recommendation of “Hold” by Analysts” was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/07/17/akorn-inc-nasdaqakrx-given-average-recommendation-of-hold-by-analysts.html.

Akorn Company Profile

Akorn Inc (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health.

Analyst Recommendations for Akorn (NASDAQ:AKRX)

Receive News & Ratings for Akorn Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akorn Inc. and related companies with MarketBeat.com's FREE daily email newsletter.